These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 35595351)

  • 1. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of lung cancer organoids in precision medicine: from bench to bedside.
    Li H; Chen Z; Chen N; Fan Y; Xu Y; Xu X
    Cell Commun Signal; 2023 Dec; 21(1):350. PubMed ID: 38057851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.
    Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH
    Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
    Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
    Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids: approaches and utility in cancer research.
    Zhou B; Feng Z; Xu J; Xie J
    Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
    Wang X; Luo Y; Ma Y; Wang P; Yao R
    Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
    Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
    Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging organoid models: leaping forward in cancer research.
    Fan H; Demirci U; Chen P
    J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.
    Waseem M; Wang BD
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer modeling meets human organoid technology.
    Tuveson D; Clevers H
    Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
    Yuan J; Li X; Yu S
    Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.